Share

Dott. Emanuela Signori

Biography

Present atUniversità Campus Bio-Medico di Roma since 2005 as Lecturer in General Pathology at the Departmental Faculty of Medicine, Surgery and Dentistry and since 2019 at the Departmental Faculty of Sciences and Biotechnologies; from 2020 to 2023 Lecturer in Training in Laboratory Medicine 1 at the Departmental Faculty of Medicine and Surgery.
Senior Researcher at the National Research Council (CNR) - Department of Biomedical Sciences, he is Head of the Laboratory of Molecular Pathology and Experimental Oncology at the Institute of Translational Pharmacology (IFT), Tor Vergata Research Area, Rome. He conducts research in translational molecular medicine for the development of preclinical anti-tumor protocols based on the transfer of nucleic acids and pharmacological molecules by electroporation, and for the identification of biomarkers for the diagnosis of inflammatory diseases and tumors.

Curriculum

2024-2027 CNR Research Unit Coordinator of the European project HORIZON-WIDERA-2023-ACCESS-02-01, HORIZON-CSA

2024-2026 President International Society for Electroporation-Based Technologies and Treatments (ISEBTT)

2024 Eligibility for CNR Research Director following a national competition

2023-2026 Scientific Consultant at Medical University-Plovdiv, Bulgaria, for the European project National plan for recovery and sustainability – NextGenerationEU.

2023 National Scientific Qualification for Full Professor 06N1 – Sciences of health professions and applied medical technologies MED/46

2022 President Elect International Society for Electroporation-Based Technologies and Treatments (ISEBTT)

Since 2022 Associate Editor Bioelectricity Journal-Mary Ann Liebert Ed.

From 2020 Representative member of the CNR-IFT at the Bioelectrics Consortium and at the National Interuniversity Research Center on Interactions between Electromagnetic Fields and Biosystems (ICEmB.org)

Since 2019 Ed Board Member Vaccines Journal-MDPI

Since 2018 CNR Auditor for MISE-Sustainable Growth Fund projects

2018 Eligibility as Senior CNR Researcher following a national competition with subsequent taking up of service with recognized length of service

2015 National Scientific Qualification Professor Second band 05E2 – Molecular Biology BIO/11

2014 National Scientific Qualification Professor Second level 06N1 – Sciences of health professions and applied medical technologies MED/46

Since 2013 Visiting professor and visiting researcher, CONICET and Faculty of Exact and Natural Sciences, University of Buenos Aires(AG);

2013 Visiting professor, CNRS-IPBS and Faculté des Science et Ingenierie Université III Toulouse, Toulouse (FR)

since 2008 Visiting professor, ERASMUS Progr., University of Plovdiv, School of Medicine,(BG)

2007, 2009 and 2010 Visiting professor, ERASMUS Progr., Catholic University of Leuven, School of Medicine, Leuven (BE)

Since 2006 Laboratory Manager at CNR-IFT

From 2005-2006 Lecturer, teaching General Pathology, UCBM, Departmental Faculty of Medicine and Surgery

2003-2005 Discipline tutor for the teaching of General Pathology, UCBM, Faculty of Medicine and Surgery

2003 PhD in Experimental Oncology and Molecular Pathology, University of Foggia, Faculty of Medicine and Surgery

2002-2005 Personal Tutor, UCBM

2001-2018 Researcher at CNR, Institute of Neurobiology and Molecular Medicine (INMM)

2000 Visiting researcher at Imperial College, School of Medicine, Hammersmith Hospital, Gene Targeting Unit, London (UK)

1993-2001 Scholarship or contract researcher at CNR, Institute of Experimental Medicine

1992 Degree from the Faculty of Mathematical, Physical and Natural Sciences, University of Rome “La Sapienza”

PUBLICATIONS

List limited to 2025-2017:

Marino R et al, Bioelectricity 2025; 7(3)

De Robertis et al, Molec Ther Nucleic Acids 2025; 36(1):102448

De Robertis et al, Methods Mol Biol. 2024;2773:157-163.

De Robertis et al, Methods Mol Biol. 2024;2773:51-58.

Cancellier R et al, Front Chem. 2023, 11:1251360

Mr. E, Phys Life Rev. 2023, 47:3-5

Tellado M et al, Vaccines 2023, 11(6):1033

De Robertis M et al, Cells 2022, 11, 3568.

Chancellor R et al, Biosensors and Bioelectronics 2022, 213, 114467.

Tellado M et al, Cancer Drug Resistance 2022, 5:595-611.

Luz J, et al. Vaccines 2021, 9(7):727.

Komel T, et al. Bioelectrochemistry 2021,141:107843 .

Chancellor R, et al. Electrochemistry Communications 2020, 121:106862.

Maglietti F, et al. Vaccines 2020, 8(3):537.

Sieni E, et al. Cancers 2020, 12(4),1043.

Peri D, et al. Comput Methods Programs Biomed. 2020,186:105204.

Tellado MN, et al. Radiol Oncol. 2020, 7;54(1):68-78.

Dettin M, et al. Cells 2019, 8(11),1470.

De Robertis M, et al. Cancers 2018, 10(11), 405.

De Robertis M, et al. Molecular Cancer 2018, 17:169.

De Robertis M, et al. Semin Cancer Biol. 2018, 53:232-247.

M. Marino, et al. Electrochemistry Acta 2017, 255C:463-471.

Lamprehet Tratar U, et al. Mediators of Inflammation 2017, 2017 Article ID 5285890.

Roles in the University

QUICK LINKS
[] magnifiercrossmenuchevron-downchevron-leftchevron-right